Quantitative Clinical Radiobiology

References

• Thames H D. On the origin of dose fractionation regimens in radiotherapy. Semin Rad Oncol 1992; 2: 3–9
   Google Scholar
• Fletcher G H. Regaud lecture: Perspectives on the history of radiotherapy. Radiother Oncol 1988; 12: 253–71
   Google Scholar
• Baclesse F. Roentgentherapy of carcinoma of the larynx. J Faculty Radiol 1951; 3: 3–12
   Google Scholar
• Holthusen H. Erfahrungen über die Verträglichkeitsgrenze für Röngenstrahlen und deren Nutzanwendung zur Ver-hütung von Schäden. Strahlentherapie 1936; 57: 254–69
   Google Scholar
• Zuppinger A. Spätveränderungen nach protrahiert-fraktion-ierter Röntgenbestrahlung im Bereich der Oberen Luft- und Speisewege. Strahlentherapie 1941; 70: 361–442
   Google Scholar
• Strandqvist M. Studien über die kumulative Wirkung der Röntgenstrahlen bei Fraktionierung. Acta Radiol 1944; 55((Suppl.))1–300
   Google Scholar
• Munro T R, Gilbert C W. The relation between tumour lethal doses and the radiosensitivity of tumour cells. Br J Radiol 1961; 34: 246–51
   PubMed Web of Science ®Google Scholar
• Cohen L. Clinical radiation dosage, Pt. II. Br J Radiol 1949; 22: 706–13
   PubMed Web of Science ®Google Scholar
• Ellis F. Dose, time and fractionation: a clinical hypothesis. Clin Radiol 1969; 20: 1–7
   PubMedGoogle Scholar
• Liversage W E. A critical look at the ret. Br J Radiol 1971; 44: 91–100
   PubMed Web of Science ®Google Scholar
• Montaque E D. Experience with altered fractionation in radiation therapy of breast cancer. Radiology 1968; 90: 962–6
   Google Scholar
• Bates T D, Peters L J. Dangers of the clinical use of the NSD formula for small fraction numbers. Br J Radiol 1975; 48: 773
   PubMed Web of Science ®Google Scholar
• Fletcher G H, Barkley H T. Present status of the time factor in clinical radiotherapy. Part I. The historical background of the recovery exponents. J Radiol Electrol 1974; 55: 43–50
   Google Scholar
• Withers H R, Peters L J. Biological aspects of radiation therapy. Textbook of radiotherapy, G H Fletcher. Lea & Febiger, Philadelphia 1980; 103–80
   Google Scholar
• Singh K. Two regimens with the same TDF but differing morbidity used in the treatment of stage III carcinoma of the cervix. Br J Radiol 1978; 51: 357–62
   PubMed Web of Science ®Google Scholar
• Handa K, Edoliya T N, Pandey R P, Agarwal Y C, Sinha N. A radiotherapeutic clinical trial of twice per week vs. five times per week in oral cancer. Strahlentherapie 1980; 156: 626–31
   PubMedGoogle Scholar
• Bentzen S M, Overgaard M, Thames H D. Fractionation sensitivity of a functional endpoint: Imparied shoulder movement after postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys 1989; 17: 531–7
   PubMed Web of Science ®Google Scholar
• Overgaard M, Bentzen S M, Christensen J J, Hjøllund Mad-Sen E. The value of the NSD formula in equation of acute and late radiation complications in normal tissue following 2 and 5 fractions per week in breast cancer patients treated with postmastectomy radiotherapy. Radiother Oncol 1987; 9: 1–12
   PubMed Web of Science ®Google Scholar
• Turesson I, Notter G. The influence of fraction size in radiotherapy on the late normal tissue reaction. I. Comparison of the effect of daily and once-a-week fractionation on human skin. Int J Radiat Oncol Biol Phys 1984; 10: 593–8
   PubMed Web of Science ®Google Scholar
• Turesson I, Notter G. The influence of fraction size in radiotherapy on the late normal tissue reaction. II. Comparison of the effects of daily and twice-a-week fractionation on human skin. Int J Radiat Oncol Biol Phys 1984; 10: 599–606
   PubMed Web of Science ®Google Scholar
• Bentzen S M. Time-dose relationships for human tumors: estimation from non-randomized studies. Current topics in clinical radiobiology of tumours, H P Beck-Bornholt. Springer-Verlag, Berlin 1993
   Google Scholar
• Fowler J F, Lindstrom M. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 1992; 23: 457–67
   PubMed Web of Science ®Google Scholar
• Cohen L. A cell population kinetic model for fractionated radiation therapy. I. Normal tissues. Radiology 1971; 101: 419–27
   PubMed Web of Science ®Google Scholar
• Hjelm-Hansen M. Laryngeal carcinoma. IV. Analysis of treatment results using the Cohen model. Acta Radiol Oncol 1980; 19: 3–12
   PubMed Web of Science ®Google Scholar
• Parsons J T, Bova F J, Million R R. A re-evaluation of split-course technique for squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1980; 6: 1645–52
   PubMed Web of Science ®Google Scholar
• Overgaard J, Hjelm-Hansen M, Johansen L V, Andersen A P. Comparison of conventional and split-course radiotherapy as primary treatment in carcinoma of the larynx. Acta Oncol 1988; 27: 147–52
   PubMed Web of Science ®Google Scholar
• Thames H D, Withers H R, Peters L J, Fletcher G H. Changes in early and late radiation resonses with altered dose fractionation: implications for dose-survival relationships. Int J Radiat Oncol Biol Phys 1982; 8: 219–26
   PubMed Web of Science ®Google Scholar
• Douglas B G, Fowler J F. The effect of multiple small doses of X-rays on skin reactions in the mouse and a basic interpretation. Radiat Res 1976; 66: 401–26
   PubMed Web of Science ®Google Scholar
• Barendsen G W. Dose fractionation, dose rate and iso-effect relationships for normal tissue responses. Int J Radiat Oncol Biol Phys 1982; 8: 1981–97
   PubMed Web of Science ®Google Scholar
• Thames H D, Hendry J H. Fractionation in radiotherapy. Taylor and Francis, London 1987; 22–52
   Google Scholar
• Thames H D. An ‘incomplete-repair’ model for survival after fractionated and continuous irradiations. Int J Radiat Biol 1985; 47: 319–39
   Web of Science ®Google Scholar
• Bentzen S M, Overgaard M, Thames H D, Christensen J J, Overgaard J. Early and late normal-tissue injury after post-mastectomy radiotherapy alone or combined with chemotherapy. Int J Radiat Biol 1989; 56: 711–5
   PubMed Web of Science ®Google Scholar
• Bentzen S M, Overgaard M. Early and late normal-tissue injury after postmastectomy radiotherapy. Early and late side-effects after radiotherapy, H Frommholdt. Springer, Berlin 1993
   Google Scholar
• Bentzen S M, Overgaard M. Relationship between early and late normal-tissue injury after postmastectomy radiotherapy. Radiother Oncol 1991; 20: 159–65
   PubMed Web of Science ®Google Scholar
• Bentzen S M, Christensen J J, Overgaard J, Overgaard M. Some methodological problems in estimating radiobiological parameters from clinical data. Alpha/beta ratios and electron RBE for cutaneous reactions in patients treated with postmastectomy radiotherapy. Acta Oncol 1988; 27: 105–16
   PubMed Web of Science ®Google Scholar
• Bentzen S M, Thames H D, Overgaard M. Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single follow-up clinical study. Radiother Oncol 1989; 15: 267–74
   PubMed Web of Science ®Google Scholar
• Turesson I, Thames H D. Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation, and telangiectasia after 3 and 5 years' follow-up. Radiother Oncol 1989; 15: 169–188
   PubMed Web of Science ®Google Scholar
• Overgaard J. The role of radiotherapy in recurrent and metastatic malignant melanoma: a clinical radiobiological study. Int J Radiat Oncol Biol Phys 1986; 12: 867–72
   PubMed Web of Science ®Google Scholar
• Overgaard J, Overgaard M, Vejby Hansen P. Maase Hvon der. Some factors of importance in the radiation treatment of malignant melanoma. Radiother Oncol 1986; 5: 183–92
   PubMed Web of Science ®Google Scholar
• ICRU 50, Prescribing, recording, and reporting photon beam therapy. International Comission on Radiation Units and Measurements, Bethesda, (in press)
   Google Scholar
• Dutreix J. The correlation of basic and clinical data. Front Radiat Ther Oncol 1968; 2: 140–53
   Google Scholar
• Flamant R, Malaise E, Dutreix J, et al. Un essai thérapeu-tique clinique sur I'irradiation des cancers amygdaliens par faisceaux de photons ou d'electrons de 20 MeV. Eur J Cancer 1967; 3: 169–81
   Google Scholar
• Wambersie A, Zreik H, Prignot Michelle, Van Dorpe J C. Variation of RBE as a function of depth in a high energy electron beam in the first millimeters of the irradiated tissues determined by the observation of skin reactions on patients (a clinical trial). Strahlentherapie 1974; 148: 279–87
   PubMedGoogle Scholar
• Amok H I, Lageaux B, Cagna D. Radiobiological effectiveness (RBE) of megavoltage X-ray and electron beams in radiotherapy. Radiat Res 1986; 105: 58–67
   Google Scholar
• Bentzen S M, Johansen L V, Overgaard J, Thames H D. Clinical radiobiology of squamous cell carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys 1991; 20: 1197–206
   PubMed Web of Science ®Google Scholar
• Joiner M C. The dependence of radiation response on the dose per fraction. The scientific basis of modern radiotherapy, N J McNally. British Institute of Radiology, London 1989; 20–6
   Google Scholar
• Travis E L, Tucker S L. Isoeffect models and fractionated radiation therapy. Int J Radiat Oncol Biol Phys 1987; 13: 283–7
   PubMedGoogle Scholar
• Bentzen S M, Thames H D. Is there an influence of overall treatment time in the response of lung to fractionated rddiotherapy? Radiother Oncol 1989; 14: 171–3
   Google Scholar
• Tucker S L, Travis E L. Comments on a time-dependent version of the linear-quadratic model. Radiother Oncol 1990; 18: 155–63
   PubMed Web of Science ®Google Scholar
• Bentzen S M, Overgaard J, Thames H D, et al. Clinical radio-biology of malignant melanoma. Radiother Oncol 1989; 16: 169–82
   PubMed Web of Science ®Google Scholar
• Bentzen S M. Steepness of the clinical dose-control curve and variation in the in vitro radiosensitivity of head and neck squamous cell carcinoma. Int J Radiat Biol 1992; 61: 417–23
   PubMed Web of Science ®Google Scholar
• Withers H R, Taylor J MG, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 1988; 27: 131–46
   PubMed Web of Science ®Google Scholar
• Bentzen S M, Thames H D. Clinical evidence for tumor clonogen regeneration: interpretations of the data. Radiother Oncol 1991; 22: 161–6
   PubMed Web of Science ®Google Scholar
• Bentzen S M, Thames H D. Overall treatment time and tumor control dose for head and neck tumors: The dog leg revisited. Radiother Oncol 1992; 25: 143–4
   PubMed Web of Science ®Google Scholar
• Slevin N J, Hendry J H, Roberts S A, Agren-Cronqvist A. The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy. Radiother Oncol 1992; 24: 215–20
   PubMed Web of Science ®Google Scholar
• Gay D M. Subroutines for unconstrained minimization using a model/trust-region approach. ACM Trans Math Software 1983; 9: 503–24
   Web of Science ®Google Scholar
• Thames H D, Rozell M E, Tucker S L, Ang K K, Fischer D R, Travis E L. Direct analysis of quantal radiation response data. Int J Radiat Biol 1986; 49: 999–1009
   Web of Science ®Google Scholar
• Bentzen S M, Thames H D, Tucker S L, Smith C. New options in direct analysis of dose—response data. lnt J Radiat Biol 1990; 57: 221–5
   PubMed Web of Science ®Google Scholar
• Bentzen S M, Thames H D. Incidence and latency of radiation reactions. Radiother Oncol 1989; 14: 261–2
   PubMed Web of Science ®Google Scholar
• Bentzen S M, Thames H D, Travis E L, et al. Direct estimation of latent time for radiation injury in late-responding normal tissues: gut, lung and spinal cord. Int J Radiat Biol 1989; 55: 27–43
   PubMed Web of Science ®Google Scholar
• Bentzen S M, Turesson J, Thames H D. Fractionation sensitivity and latency of telangiectasia after postmastectomy radiotherapy. A graded response analysis. Radiother Oncol 1990; 18: 95–106
   PubMed Web of Science ®Google Scholar
• McCullagh P. Regression models for ordinal data. J R Statist Ser 1980; B-42: 109–42
   Google Scholar
• Thames H D, Bentzen S M, Turesson I, Overgaard M, van den Bo-Gaert W. Time-dose factors in radiotherapy. Radiother Oncol 1990; 19: 219–35
   PubMed Web of Science ®Google Scholar
• Bentzen S M, Pedersen D, Overgaard J. Clinical radiobiology of rectal complications after combined brachytherapy and external radiotherapy for cancer of the uterine cervix (Abstract). ESTRO 11th Annual Meeting. 1992
   Google Scholar
• Turesson I. The progression rate of late radiation effects in normal tissues and its impact on dose—response relationships. Radiother Oncol 1989; 15: 217–26
   PubMed Web of Science ®Google Scholar
• Peters L J, Ang K K, Thames H D. Accelerated fractionation in the radiation treatment of head and neck cancer. A critical comparison of different strategies. Acta Oncol 1988; 27: 185–94
   PubMed Web of Science ®Google Scholar
• Peracchia G, Saki C. Radiotherapy with thrice-a-day fractionation in a short overall time: clinical experiences. Int J Radiat Oncol Biol Phys 1981; 7: 99–104
   PubMed Web of Science ®Google Scholar
• Bentzen S M, Overgaard M, Overgaard J. Clinical correlations between late normal-tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity. Eur J Cancer 1993, in press
   Google Scholar
• Tucker S L, Turesson I, Thames H D. Evidence for individual differences in the radiosensitivity of human skin. Eur J Cancer 1992; 28A: 1783–91
   PubMed Web of Science ®Google Scholar
• Taylor A MR, Harnden D G, Arlett C F, et al. Ataxia-telangiectasia: a human mutation with abnormal radiation sensitivity. Nature 1975; 258: 427–9
   PubMed Web of Science ®Google Scholar
• Swift M, Reitnauer P J, Morrell D, Chase C L. Breast and other cancers in families with ataxia-telangiectasia. N Engl J Med 1987; 316: 1289–94
   PubMed Web of Science ®Google Scholar
• Weeks D E, Paterson M C, Lange K, et al. Assesment of chronic τ radiosensitivity as an in vitro assay for het-erozygote identification of ataxia-telangiectasia. Radiat Res 1991; 128: 90–9
   PubMed Web of Science ®Google Scholar
• Paterson M C, Anderson A K, Smith B P, Smith P J. Enhanced Radiosensitivity of cultured fibroblasts from ataxia telangiectasia heterozygotes manifested by defective colony-forming ability and reduced DNA repair replication after hypoxic †-irradiation. Cancer Res 1979; 39: 3725–34
   PubMed Web of Science ®Google Scholar
• Maciejewski B, Withers H R, Taylor J MG, Hliniak A. Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose—response and repopulation. Int J Radiat Oncol Biol Phys 1989; 16: 831–43
   PubMed Web of Science ®Google Scholar
• Sause W T, Cooper J S, Rush S, et al. Fraction size in external beam radiation therapy in the treatment of melanoma. Int J Radiat Oncol Biol Phys 1991; 20: 429–32
   PubMed Web of Science ®Google Scholar
• Trott K R. The optimal radiation dose per fraction for the treatment of malignant melanomas. Int J Radiat Oncol Biol Phys 1991; 20: 905–7
   Google Scholar
• Lindstrom M, Fowler J F. Re-analysis of the time factor in local control by radiotherapy of T3 T4 squamous cell carcinoma of the larynx. Int J Radiat Oncol Biol Phys 1991; 21: 813–7
   PubMed Web of Science ®Google Scholar
• Overgaard J. Sensitization of hypoxic tumour cells—clinical experience. Int J Radiat Biol 1989; 56: 801–11
   PubMed Web of Science ®Google Scholar
• Zagars G K, Schultheiss T E, Peters L J. Inter-tumor heterogeneity and radiation dose—control curves. Radiother Oncol 1987; 8: 353–62
   PubMed Web of Science ®Google Scholar
• West C ML, Davidson S E, Hendry J H, Hunter R D. Prediction of cervical carcinoma response to radiotherapy. Lancet 1991; 338: 818
   PubMed Web of Science ®Google Scholar
• Bentzen S M, Thames H D, Overgaard J. Does variation in the in vitro cellular radiosensitivity explain the shallow clinical dose-control curve for malignant melanoma? Int J Radiat Biol 1990; 57: 117–26
   Google Scholar
• Withers H R, Taylor J MG, Maciejewski B. Treatment volume and tissue tolerance. Int J Radiat Oncol Biol Phys 1988; 14: 751–9
   PubMed Web of Science ®Google Scholar
• Overgaard J, Bentzen S M. Radiotherapy alone or combined with hyperthennia in the treatment of advanced malignant melanoma. Pigment cell: Therapy of advanced malignant melanoma, Ph Rümke. S. Karger, Basel 1990; 14–35
   Google Scholar
• Fowler J F. How worthwhile are short schedules in radiotherapy?: A series of exploratory calculations. Radiother Oncol 1990; 18: 165–81
   PubMed Web of Science ®Google Scholar
• Price P, Hoskins P J, Easton D, Austin D, Palmer S G, Yarnold J R. Prospective radnomised trial of single and multifraction radiotheraphy schedules in the treatment of painful bony metastases. Radiother Oncol 1986; 6: 247–55
   PubMed Web of Science ®Google Scholar
• Wang C C, Blitzer P H, Suit H D. Twice-a-day rddiaiton therapy for cancer of the head and neck. Cancer 1985; 55: 2100–4
   PubMed Web of Science ®Google Scholar
• Saunders M I, Dische S. Radiotherapy employing three fractions in each day over a continuous period of 12 days. Br J Radiol 1986; 59: 523–5
   PubMedGoogle Scholar
• Knee R, Fields R S, Peters L J. Concomitant boost radiotherapy for advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1985; 4: 1–7
   PubMed Web of Science ®Google Scholar
• Ang K K, Peters L J, Weber R S, et al. Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys 1990; 19: 1339–45
   PubMed Web of Science ®Google Scholar
• Begg A C, Hofland I, Moonen L, et al. The predictive value of cell kinetics measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an interim report. Int J Radiat Oncol Biol Phys 1990; 19: 1449–53
   PubMed Web of Science ®Google Scholar
• Marcial V A, Pajak T F, Chang C, Tupchong L, Stetz J. Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity, pharynx. larynx, and sinuses, using radiation therapy as the only planned modality: (preliminary report) by the Radiation Therapy Oncology Group (RTOG). Int J Radiat Oncol Biol Phys 1987; 13: 41–7
   PubMed Web of Science ®Google Scholar
• Thames H D, Peters L J, Ang K K. Time-dose considerations for normal-tissue tolerance. Radiation tolerance of normal tissues. Frontiers in radition therapy and oncology, J M Vaeth, J L Meyer. Karger, Basel 1989; 113–30
   Google Scholar
• Honor J-C, Bogaert Wvan den Ang K K, . European Organization for Research on Treatment of Cancer trials using radiotherapy with multiple fractions per day. Frontiers of radiation therapy and oncology, J M Vaeth, J Meyer, et al. S. Karger, Basel 1988; vol. 22: 149–61
   Google Scholar
• Horiot J C. Le Fur R, N'Guyen T, et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 1992; 25: 231–41
   PubMed Web of Science ®Google Scholar
• Peters L J, Brock W A, Chapman J D, Wilson G, Fowler J F. Response predictors in radiotherapy: a review of research into radiobiologically based assays. Br J Radiol 1988, (Suppl. 22): 96–108
   Google Scholar
• Bentzen S M, Balslev I, Pedersen M, et al. Time to loco-regional recurrence after resection of Dukes' B and C col-orectal cancer with or without postoperative radiotherapy. A multivariate regression analysis. Br J Cancer 1992; 65: 102–7
   PubMed Web of Science ®Google Scholar
• Tucker S L. Tests for the fit of the linear-quadratic model to radiation isoeffect data. Int J. Radiat Oncol Biol Phys 1984; 10: 1933–9
   PubMed Web of Science ®Google Scholar
• Vegesna V, Withers H R, Taylor J MG. Epilation in mice after single and multi-fractionated irradiation. Radiother Oncol 1988; 12: 233–9
   PubMed Web of Science ®Google Scholar
• Taylor J MG, Kim D K. The poor statistical properties of the Fe-plot. Int J Radiat Biol 1989; 56: 161–7
   PubMed Web of Science ®Google Scholar
• Overgaard M. The clinical implication of non-standard fractionation. Int J Radiat Oncol Biol Phys 1985; 11: 1225–6
   PubMed Web of Science ®Google Scholar
• Overgaard M. Radiation-induced spontaneous ribfractures in breast cancer patients treated with postmastectomy irradiation. A clinical radiobiological analysis of fraction size and dose response relationships on late bone damage. Acta Oncol 1988; 27: 117–22
   PubMed Web of Science ®Google Scholar
• VanLimbergen E, Rijnders A, Schueren Evd, Lerut T, Christiaens R. Cosmetic evaluation of breast conserving treatment for mammary cancer. 2. A quantitative analysis of the influence of radiation dose, fractionation schedules and surgical treatment techniques on cosmetic results. Radiother Oncol 1989; 16: 253–67
   Google Scholar